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The Journal of Investigative Dermatology Symposium Proceedings is the
``sister'' journal of the Journal of Investigative Dermatology. It is usually
published two to three times per year, and contains collections of
articles presented at international meetings of interest to investiga-
tive dermatologists and cutaneous biologists. Papers presented at
one particular meeting, the Montagna Annual Symposium on the
Biology of the Skin, are traditionally published each year in the JID
Symposium Proceedings. Montagna Symposia have a long history of
bringing together scientists from varying backgrounds in an
informal and productive environment to discuss important issues
in cutaneous biology. In 2000, the Montagna Symposium explored
the topic of ``Emerging Infections and the Skin''. Research updates
presented at this meeting were published in the December 2001
issue of the JID Symposium Proceedings, and it is my intent to draw
attention to the material presented in that particular issue.
One common theme that is not immediately obvious among the
manuscripts is that infectious diseases, both ``old'' and ``new'', have
emerged in the setting of overall improvement in health care.
Health improvement has largely occurred in developed nations, and
has led to an increase in life span and to better quality of life in
general. For example, improved chemotherapeutic agents for
cancer, effective antiretroviral treatment for HIV disease and the
increased use of bone marrow and solid organ transplantation for a
variety of conditions have led to increased survival rates for patients.
These gains, however, have also led to an increasingly older
population, often with varying degrees of altered immune function.
Choi and Lerner outline how altered immunity has led to the
``emergence'' of Leishmaniasis in HIV-infected individuals. In
particular, they comment on the tremendous number of cases of
coinfected patients in Spain, as well as highlighting the tendency
toward visceral Leishmaniasis in the setting of HIV infection.
LaGuardia and Gilden describe in detail the many noncutaneous
neurologic manifestations of varicella-zoster virus infection, and
emphasize the increased occurrence of these complicated disease
presentations in elderly and immunocompromised patients.
Blauvelt points out that Kaposi's sarcoma-associated herpesvirus
(KSHV) infection is usually asymptomatic, but that immune
compromise, as triggered by age, immunosuppressive medications
or HIV infection, can lead to the occurrence of Kaposi's sarcoma
(KS). Jenson et al and Bouwes Bavinck et al discuss the biology of
human papillomavirus (HPV) infection, and discuss possible
mechanisms involved in the development of HPV-associated
neoplasia, especially as it relates to skin cancer development in
post-transplant patients who are taking immunosuppressive med-
ications to prevent graft rejection. Ghannoum documents the
important clinical problem of the emergence of unusual, aggressive
and drug-resistant Candida species in the setting of widespread use
of chemotherapy and antifungal therapy in cancer patients.
Another theme that is carried through many of the articles is that
technologic advances have facilitated studies of infectious disease
pathogenesis. In this regard, Fredericks discusses how pro®ling 16s
rRNA sequences has led to the identi®cation of numerous new
bacterial species and to the cataloguing of bacterial populations in
complex ecosystems (e.g., soil). He stresses that such technology
will be extremely useful in delineating bacterial populations within
skin and to linking abnormal 16s RNA pro®les with cutaneous
disease states, such as acne and rosacea. Novel experimental systems
and approaches, as described in the papers by Chiller et al and
Travers et al, have led to better understanding of diseases caused by
S. aureus. Blauvelt outlines how new methodologies in molecular
virology led to the discovery of KSHV in KS tissue, and to
identi®cation of the link between human herpesvirus 6 and 7
infection and roseola (and possibly to pityriasis rosea). A fascinating
review by King et al explores how advances in molecular biology
have given strength to the hypothesis that Chlamydia pneumoniae is
involved in pathogenesis of diseases traditionally believed to be of
noninfectious etiology (e.g., atherosclerosis and diabetic foot
ulcers). Connick describes how technologic advances in immunol-
ogy have led to extremely detailed analyzes of immune function in
HIV-infected individuals, both prior and following antiretroviral
therapy. Clever use of skin explants in tissue culture experiments, as
shown by Marovich et al, led to the discovery that dengue virus
infects Langerhans cells. This work has provided a new appreciation
of dengue virus pathogenesis and will likely lead to new
immunization strategies for dengue fever. Finally, Boehncke
provides an excellent example of how methodologic advances in
mouse modeling of psoriasis have contributed to understanding
how bacterial superantigens exacerbate psoriasis.
It is clear that the many advances in understanding infectious
disease pathogenesis will translate into better vaccine and
therapeutic approaches in the future. The reviews by Carrasco
et al and Dinarello provide a glimpse of this hope. The former paper
describes considerable advances that have been made to develop
both prophylactic and therapeutic vaccines for HPV disease.
Importantly, success in this area should help many women at risk
for development of cervical cancer. Dinarello outlines current
understanding on the immunology and cytokine biology of septic
shock (especially as it relates to TNF-a and IL-1), and provides a
rational basis for therapeutic interventions in sepsis designed to
interfere with these key cytokines. Finally, I would like to
emphasize that Connick, in her speci®c discussion of immune
defects in HIV disease and the improvement of many of these
parameters with anti-retroviral therapy, provides an excellent
paradigm for understanding the complex interplay between
immune status and infectious disease pathogenesis. Accumulating
evidence suggests that future therapeutic approaches for infectious
disease will not only require speci®c targeting of pathogens, but
will also likely involve immunotherapeutic approaches that
enhance natural defenses against these organisms. ``That'' issue of
JID Symposium Proceedings provides an up-to-date road map
for infectious diseases in dermatology and should be carefully
perused.
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